Guardant Health
GH
168.33
-2.36
-1.38%
Guardant Health
US · GH
#820 by market cap
Listed 2018
168.33
-2.36
-1.38%
Live - 5344 symbols - heartbeat 426s ago
· 2026-10-08 07:03
Pre-market
168.33
0.00%
After-hours
168.33
0.00%
Overnight
167.98
-0.21%
- Market cap
- 22.59B
- P/E (TTM)i
- -47.96
- P/Bi
- -101.34
- EPSi
- -3.32
- Div yieldi
- 0.00%
- 52W posi
- 83%
Reader sentiment
Are you bullish or bearish on GH?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 6 in the most recent period (2026/Q3).
- Total institutional ownership fell 1.1 percentage points.
Institutional ownership
- Held by institutions
- 100.84% -1.13pp
- Institutions
- 707 -6
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund74.50%
Hedge Fund13.76%
VC/PE Fund4.03%
Individual/Insider3.48%
Private Company3.00%
Public Company2.92%
Sovereign Wealth Fund1.16%
Government Pension Fund1.11%
Insurance Company0.20%
Top holders as of 2026-06-30
BlackRock
5.68% · 7.62M sh
Vanguard Capital Management, LLC
4.92% · 6.60M sh
T. Rowe Price Group, Inc.
4.85% · 6.51M sh
Vanguard Portfolio Management, LLC
4.06% · 5.45M sh
FMR
3.99% · 5.35M sh
Invesco Ltd.
3.07% · 4.11M sh
Two Sigma Investments, LP
2.77% · 3.72M sh
Capital Research
2.53% · 3.40M sh
Deep Track Capital, LP
2.53% · 3.39M sh
Columbia Management Investment Advisers, LLC
2.35% · 3.15M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 20 buys · 30 sells
| Name | Role | Stake |
|---|---|---|
| Helmy Eltoukhy | Co-Founder, Co-CEO & Chairman | 1.74% |
| AmirAli Talasaz | Co-Chief Executive Officer | 1.39% |
| Darya Chudova | Chief Technology Officer | 0.06% |
| Craig Eagle | Chief Medical Officer | 0.05% |
| Christopher Freeman | Chief Commercial Officer | 0.05% |
| Michael Bell | Chief Financial Officer | 0.04% |
| Kumud Kalia | Chief Information Officer | 0.03% |
| John Saia | Chief Legal Officer | 0.03% |
| Vijaya Gadde | Independent Director | 0.02% |
| Terilyn Monroe | Chief Human Resources Officer | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-30 | Kumud Kalia | Chief Information Officer | Derivative Exercise and Sale | -3,067 | $174.75 |
| 2026-09-30 | Kumud Kalia | Chief Information Officer | Derivative Exercise and Retained | +2,979 | -- |
| 2026-09-30 | Helmy Eltoukhy | Co-Founder, Co-CEO & Chairman | Derivative Exercise and Sale | -18,515 | $174.75–178.36 |
| 2026-09-30 | Helmy Eltoukhy | Co-Founder, Co-CEO & Chairman | Derivative Exercise and Retained | +18,015 | -- |
| 2026-09-30 | Michael Bell | Chief Financial Officer | Derivative Exercise and Sale | -3,914 | $174.75 |
| 2026-09-30 | Michael Bell | Chief Financial Officer | Derivative Exercise and Retained | +3,366 | -- |
| 2026-09-30 | AmirAli Talasaz | Co-Chief Executive Officer | Derivative Exercise and Sale | -18,515 | $174.75–178.36 |
| 2026-09-30 | AmirAli Talasaz | Co-Chief Executive Officer | Derivative Exercise and Retained | +18,015 | -- |
| 2026-09-30 | Terilyn Monroe | Chief Human Resources Officer | Derivative Exercise and Sale | -2,098 | $174.75 |
| 2026-09-30 | Terilyn Monroe | Chief Human Resources Officer | Derivative Exercise and Retained | +1,921 | -- |
| 2026-09-30 | John Saia | Chief Legal Officer | Derivative Exercise and Sale | -3,706 | $174.75 |
| 2026-09-30 | John Saia | Chief Legal Officer | Derivative Exercise and Retained | +3,357 | -- |
| 2026-09-30 | Christopher Freeman | Chief Commercial Officer | Derivative Exercise and Sale | -3,143 | $174.75 |
| 2026-09-30 | Christopher Freeman | Chief Commercial Officer | Derivative Exercise and Retained | +4,273 | -- |
| 2026-09-30 | Darya Chudova | Chief Technology Officer | Derivative Exercise and Sale | -4,320 | $174.75 |
| 2026-09-30 | Darya Chudova | Chief Technology Officer | Derivative Exercise and Retained | +3,713 | -- |
| 2026-09-20 | Roberto Mignone | Director | Derivative Exercise and Retained | +264 | -- |
| 2026-09-16 | Manuel Hidalgo Medina | Director | Derivative Exercise and Retained | +232 | -- |
| 2026-09-15 | Steve Krognes | Independent Director | Open Market Disposition | -6,674 | $174.46–177.48 |
| 2026-09-15 | Alex Azar | Director | Open Market Disposition | -826 | $175.00 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:03:28 · For reference only, not investment advice and not tailored to your situation.